Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

All GLG News Analyses Filed Under: Business of Medicine

Articles with lock require a GLG News subscription
Adam Fein Posted June 2, 2008
NABP Exposes Fake Candian Online Pharmacies
Analysis of:  NABP Names 79 Internet Drug Outlets Operating in Conflict With Patient Safety and Pharmacy Practice Standards | news.yahoo.com
Author: Adam Fein, Founder & President Pembroke Consulting Inc
The National Association of Boards of Pharmacy (NABP) named 79 online pharmacies that are not safe for patients. Rather than a general “watch out” message, the NABP actually listed the web addresses for these rogue sources.  Many sites falsely claim to be “Canadian” pharmacies.  This was an...
Posted June 2, 2008
GlaxoSmithKline given OK to sell bird-flu vaccine in Europe
Analysis of: GlaxoSmithKline given OK to sell bird-flu vaccine in Europe | www.bizjournals.com
Author: GLG Member Program Contributor
-Glaxo's pre-pandemic flu vaccine is a double opportunity - a chance to contract now with multiple governments to supply a pre-pandemic vaccine as well as a natural segue to become their future supplier of actual pandemic flu vaccine (when developed).  -When pandemic flu hits, the race will be...
Posted June 2, 2008
China Muscles In On The Generics Industry
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
China, buoyed by its recent economic boom, is invading industrilaized nation markets with many generic compounds , from pain killers to AIDS drugs. Chinese drugs are cheap, but have reputation for poor quality , especially with recent heparin fiasco. India has had a good track record with generics and...
Posted May 30, 2008
Part D Claims Data to be used in Patient-Safety Initiatives
Analysis of: Part D Claims Data to be used in Patient-Safety Initiatives | www.modernhealthcare.com
Author: GLG Member Program Contributor
The Center for Medicare and Medicaid Services (CMS), the financier for the Medicare and Medicaid Programs, has decided in final regulations to permit access of its vast and rapidly growing Part D data stores to the Food and Drug Administration , other government agencies and academic researchers to...
Posted May 27, 2008
China Muscles In On The Generics Industry
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
With the recent scandals around quality, one needs to look at China's government stepping in and improving the quality. Expect additional testing requirements and regulatory requirements consider the added cost of companies sending QA teams into China to support their development
Posted May 27, 2008
China Muscles In On The Generics Industry
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
Cost of goods in China are increasing dramatically over the last few years The cost of compliance has and will increase dramatically as well. The internal regulatory costs for compliance has increased as well. Working with China is not cheap and we should look at China more as a part of a strategic...
Posted May 27, 2008
Look to England's example for ways to solve America's health-care problem
Analysis of: Look to England's example for ways to solve America's health-care problem | www.sltrib.com
Author: GLG Member Program Contributor
A single payer, national system does work, but may not necessarily be in the best interest of all parties.   Yes this type of system is 'free' to the users, but is funded through higher taxes than paid in the US.
Posted May 27, 2008
China Muscles In On The Generics Industry
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
The Chinese government funded many manufacturing plants for biologics about 15 years ago, and many are bankrupt because of noninforced patent laws
Posted May 27, 2008
Warning over drug trial’s effects on testing
Analysis of: Warning over drug trial’s effects on testing | www.ft.com
Author: GLG Member Program Contributor
Direct comparisons between potential competing agents often do not exist Initial FDA approval is usually based on comparisons to placebo A new approval does necessarily mean that the new agent is better than existing ones, although this is implied by industry Industry bears all the costs of efficacy...
Posted May 23, 2008
China Muscles In On The Generics Industry
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
How can safety be verified with the Chinese history of contaminants in the toy and food industries.  I certainly would not want to take Chinese drugs. lynn tucker
Previous Page : 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Next121 to 130 of 575

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses

Azilect
September 2, 2008

Byetta Saves Lives
September 2, 2008

The Devil Is in the Details
September 1, 2008

Dangers of Methadone Usage
August 28, 2008

Healthways A Market Downturn and Results
August 26, 2008

 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-09-05T13:45:17.290